The Singapore Therapeutics Development Review (STDR) will be launching the Call for Applications for Pilot Letters of Intent on 20 February 2023.
STDR is a competitive, commercially-driven process that aims to boost the quality and quantity of local drug development and biotech pipelines through provision of funding support for promising drug discovery and development projects.
- STDR will fund therapeutic projects in areas such as small molecules, large molecules, cell and gene therapies and platform technologies.
- Awardees will receive post-award guidance from mentors, as well as attend bootcamps and training in biotech business development.
A virtual roadshow will be held on the same day, 20 February 2023, 11 am – 12:15 pm, where the STDR Secretariat will share administrative details on the grant call and tips on writing a strong application.
Click to register for the STDR Virtual Roadshow here.
Detailed information on the application procedure and review process will be provided upon the launch of the call on 20 February 2023.
